Cynomolgus monkey only for pivotal tox (rabbit dropped after early studies)
“She agreed, as the Applicant proposed, that the monkey alone should be used in the planned 6-month chronic toxicity study.”
✓ VerifiedFDA pharmacology/toxicology review, p. 26Source ↗
Why that species
100% VEGF sequence homology and comparable Ang-2 binding affinity in monkey; rabbit unsuitable (severe toxicity, ADA)
“The monkey was selected as the most relevant species based on 100% sequence homology (VEGF) and binding affinity (Ang-2) comparable to humans.”
✓ VerifiedFDA pharmacology/toxicology review, p. 48Source ↗
Surrogate molecule
No surrogate; clinical molecule tested in monkey (and rabbit in early studies)
“Faricimab (RO6867461) bound to full length Ang 2 with high affinity across species including human, cynomolgus monkey, rabbit, and mouse, measured by Surface Plasmon Resonance (SPR).”
✓ VerifiedFDA pharmacology/toxicology review, p. 18Source ↗